# RelayHealth Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/relayhealth

- Industry: Healthcare IT
- Headquarters: Alpharetta, US
- Website: www.relayhealth.com
- Total disclosed funding: $38M
- Latest round: Series E (Jul 29, 2003)
- Investors on record: 4

## About

RelayHealth Corporation is a healthcare technology firm focusing on improving the efficiency of healthcare communication and transactions, enhancing connectivity among patients, providers, and payers through innovative digital solutions.RelayHealth Corporation specializes in healthcare communication solutions. Founded in 1990 in Alpharetta, US, the company was acquired by McKesson Corporation in June 2006, although the financial terms of the acquisition were not disclosed. RelayHealth has completed a total of six deals, raising USD 7.00 mn during its latest funding round, primarily from investors including Cisco Systems and IKnowMed Systems.RelayHealth provides integrated healthcare communication solutions that streamline interactions between patients, providers, and payers. Its offerings include electronic prescription services, real-time eligibility checks, and secure messaging, aiming to enhance patient engagement and operational efficiency for healthcare providers. RelayHealth serves a broad network of healthcare organizations, focusing on regulatory compliance and improving care coordination.RelayHealth operates on a business-to-business (B2B) model, generating revenue through partnerships with healthcare providers and payers. Its transaction structure involves fees for electronic health record integrations and communication services, enabling better management of patient information and healthcare workflows. While specific pricing details are not publicly available, RelayHealth's solutions are designed to enhance operational efficiencies in healthcare settings.Looking ahead, RelayHealth plans to expand its suite of digital health solutions with new products set to launch in the upcoming year. The company is targeting growth in new markets, particularly focusing on expanding its reach in international markets by 2025. Recent funding of USD 7.00 mn will be utilized to enhance product development and support the expansion into these new geographical areas.

## Funding rounds

- Series E, Jul 29, 2003, $6.3M — US Venture Partners, Lilly Ventures, SI Ventures, Venrock
- Series D, Aug 1, 2001, $13M — US Venture Partners, Venrock
- Series C, Feb 1, 2000, $19M — Venrock

## Investors

- Venrock (https://capitalatlas.ai/funds/venrock) — Series C, Series D, Series E
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series D, Series E
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series E
- SI Ventures (https://capitalatlas.ai/funds/si-ventures) — Series E